TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Panafarma Medical Consult AB
Closing information (x1000 NOK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
242
|
297
|
371 |
Financial expenses |
0
![]() |
0
|
2 |
Earnings before taxes |
1
|
52
|
30 |
EBITDA |
-5
|
52
|
31 |
Total assets |
373
|
363
|
443 |
Current assets |
373
|
363
|
441 |
Current liabilities |
124
|
117
|
193 |
Equity capital |
233
|
230
|
235 |
- share capital |
100
|
99
|
97 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
62.5%
|
63.4%
|
53.0% |
Turnover per employee |
121
|
148
|
186 |
Profit as a percentage of turnover |
0.4%
|
17.5%
|
8.1% |
Return on assets (ROA) |
0.3%
|
14.3%
|
7.2% |
Current ratio |
300.8%
|
310.3%
|
228.5% |
Return on equity (ROE) |
0.4%
|
22.6%
|
12.8% |
Change turnover |
-59
|
-82
|
37 |
Change turnover % |
-20%
|
-22%
|
11% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.